[Recent topics on important drugs for H. pylori eradication: Lansoprazole].
Fukuda
Yoshihiro
Y
Division of Gastroenterology, Hyogo College of Medicine.
Tomita
Toshihiko
T
Koizuka
Hiromasa
H
Aoyama
Nobuo
N
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D005745:Gastric Acidity Determination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D064747:Lansoprazole; D009853:Omeprazole / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D054328:Proton Pump Inhibitors
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D009853:Omeprazole